Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASEI.L Regulatory News (ASEI)

  • There is currently no data for ASEI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

10 Nov 2020 07:00

RNS Number : 7459E
Aberdeen Standard Equity Income Tst
10 November 2020
 

Aberdeen Standard Equity Income: New research

10/11/2020

ASEI targets above-average income and capital growth with an index-agnostic approach...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPFNELKEFFA
Date   Source Headline
20th Jul 202112:26 pmRNSNet Asset Value(s)
19th Jul 20211:13 pmRNSGearing disclosure
19th Jul 202110:41 amRNSNet Asset Value(s)
16th Jul 202110:57 amRNSNet Asset Value(s)
15th Jul 202111:00 amRNSNet Asset Value(s)
15th Jul 20219:51 amRNSPortfolio disclosure
14th Jul 202112:06 pmRNSNet Asset Value(s)
13th Jul 202112:37 pmRNSNet Asset Value(s)
12th Jul 20212:07 pmRNSGearing disclosure
12th Jul 202111:57 amRNSNet Asset Value(s)
9th Jul 202111:52 amRNSNet Asset Value(s)
8th Jul 202111:09 amRNSNet Asset Value(s)
7th Jul 20216:24 pmRNSMonth End Net Asset Value(s)
7th Jul 202112:41 pmRNSNet Asset Value(s)
6th Jul 202112:45 pmRNSNet Asset Value(s)
5th Jul 20212:27 pmRNSGearing disclosure
5th Jul 202111:41 amRNSNet Asset Value(s)
2nd Jul 20215:14 pmRNSQuarterly disclosure
2nd Jul 202111:36 amRNSNet Asset Value(s)
30th Jun 202112:44 pmRNSNet Asset Value(s)
29th Jun 202112:21 pmRNSNet Asset Value(s)
29th Jun 20217:00 amRNSNew Loan Facility
28th Jun 202112:32 pmRNSGearing disclosure
28th Jun 202111:35 amRNSNet Asset Value(s)
25th Jun 202112:37 pmRNSNet Asset Value(s)
24th Jun 202111:57 amRNSNet Asset Value(s)
23rd Jun 202112:43 pmRNSNet Asset Value(s)
22nd Jun 202112:36 pmRNSNet Asset Value(s)
21st Jun 20212:21 pmRNSGearing Disclosure
21st Jun 202112:29 pmRNSNet Asset Value(s)
18th Jun 202112:54 pmRNSNet Asset Value(s)
17th Jun 202112:49 pmRNSNet Asset Value(s)
16th Jun 202112:35 pmRNSNet Asset Value(s)
15th Jun 202112:00 pmRNSNet Asset Value(s)
14th Jun 202112:48 pmRNSGearing disclosure
14th Jun 202112:07 pmRNSNet Asset Value(s)
11th Jun 20214:40 pmRNSPortfolio disclosure
11th Jun 202111:18 amRNSNet Asset Value(s)
10th Jun 202112:08 pmRNSNet Asset Value(s)
9th Jun 202112:25 pmRNSNet Asset Value(s)
8th Jun 202112:34 pmRNSNet Asset Value(s)
7th Jun 20212:57 pmRNSGearing disclosure
7th Jun 202112:46 pmRNSNet Asset Value(s)
4th Jun 20214:08 pmRNSMonth End Net Asset Value(s)
4th Jun 202112:16 pmRNSNet Asset Value(s)
3rd Jun 202111:34 amRNSNet Asset Value(s)
2nd Jun 202112:01 pmRNSNet Asset Value(s)
1st Jun 20213:06 pmRNSGearing disclosure
28th May 202112:33 pmRNSNet Asset Value(s)
27th May 202111:35 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.